South Carolina Hepatitis C and Substance Use Disorder Symposium (Virtual)

South Carolina Hepatitis C and Substance Use Disorder Symposium

Common Ground: Caring for Patients with HCV and Substance Use Disorder Co-Morbidities in SC Symposium

Saturday, May 21, 2022

Click here to view the program flyer

To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page.

Clicking on the blue/gray bars below will expand the session details!

Registration Information: Participants must register to attend through the Southeast AETC website: https://www.seaetc.com/event/?ER_ID=86232

There is no cost to attend

If you have any questions, please call: 803-434-6430 ext. 21686

Target Audience: This educational event is for physicians, nurse practitioners, physician assistants, pharmacists, nurses and other health care professionals.

Overall Goal: This is a collaborative effort of the Ending the Epidemics South Carolina (EtE SC) steering committee, the Department of Alcohol & Other Drug Abuse Services (DAODAS), and the SC HIV Clinical Training Center. This symposium will focus on the current substance use disorder (SUD) epidemic and its synergistic effect on Hepatitis C.

Agenda:

Time	Session
9:00-9:10 am	Welcome and Greetings
9:10-10:00 am	Examining the Synergistic Epidemics: Christina Galardi, MPH, MCRP, PAHM; Marya Barker, MPH; Linda Brown, MPH
10:00-10:30 am	Clinical Perspectives on SUD Treatment: Alain Litwin, MD
10:30-10:45 am	Break
10:45-11:30 am	Clinical Perspectives on Hepatitis C and SUD: Divya Ahuja, MD, MRCP (London)
11:30-12:15 pm	Panel Discussion: Exploring available resources: Speakers: All speakers will participate in the speaker panel
12:15-12:30 pm	Question and Answer, Evaluations, and Adjournment

Date: May 21, 2022 09:00 AM - 12:30 PM

CE Hours

2.75

CE Units

0.275

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

Pharmacists must sign in at the beginning of the program, only claim credit for the sessions that they attended and participated in, in their entirety and then complete the online evaluation (with correct NABP ID and day/month of birth) within 30 days of event to ensure credit is transmitted to the CPE monitor. No partial credit will be awarded. Any credit claimed greater than 60 days will be rejected by the NABP CPE Monitor.

Sat, May 21, 2022

Examining the Synergistic Epidemics

At the completion of this activity, the participant will be able to:

Describe the trends in the rapidly changing substance use disorder crisis
Provide the current epidemiological trends in HCV infection rates
Examine the intersection of the Hepatitis and SUD Crises

Speaker(s)/Author(s)

Christina Galardi, MPH, MCRP, PAHM Public Health Analyst for Overdose Response Strategy, CDC Foundation
Linda Brown, MPH Overdose Prevention Coord/Infectious Disease Consultant, SC DAODAS
Marya Barker, MPH Director, Core Surveillance Section, SC DHEC

Activity Number

0062-9999-22-119-L01-P

Date: 05/21/22

Time: 09:10 AM - 10:00 AM

CE Hours

0.75

Clinical Perspectives on SUD Treatment

At the completion of this activity, the participant will be able to:

Discuss best practice for screening for SUD in clinical practice
Introduce expanding access to treatment options

Speaker(s)/Author(s)

Alain Litwin, MD, MPH, MS
Executive Director, Addiction Research Center; Vice Chair of Academics and Research, Prisma Health; Professor of Medicine, University of South Carolina School of Medicine–Greenville; Professor of Medicine, Clemson University School of Health Research

Activity Number

0062-9999-22-120-L01-P

Date: 05/21/22

Time: 10:00 AM - 10:30 AM

CE Hours

0.50

Clinical Perspectives on Hepatitis C and SUD

At the completion of this activity, the participant will be able to:

Discuss screening for patients with HCV and SUD co-morbidities
Describe expanded treatment options for HCV
Evaluate treatment failure vs re-infection

Speaker(s)/Author(s)

Divya Ahuja, MD, MRCP (London)
Associate Professor of Clinical Internal Medicine, Prisma Health -University of South Carolina, School of Medicine (USC SOM); Principal Investigator, South Carolina HIV/AIDS Training Center, USC SOM; Medical Director, Immunology Center, Prisma Health

Activity Number

0062-9999-22-121-L01-P

Date: 05/21/22

Time: 10:45 AM - 11:30 AM

CE Hours

0.75

Panel Discussion: Exploring available resources

At the completion of this activity, the participant will be able to:

Discuss local resources available for SUD treatment, recovery
Describe current opioid response projects in SC
Describe resources available for HCV curative treatment

Speaker(s)/Author(s)

Alain Litwin, MD, MPH, MS Executive Director, Addiction Research Center; Vice Chair of Academics and Research, Prisma Health; Professor of Medicine, University of South Carolina School of Medicine–Greenville; Professor of Medicine, Clemson University School of Health Research
Christina Galardi, MPH, MCRP, PAHM Public Health Analyst for Overdose Response Strategy, CDC Foundation
Divya Ahuja, MD, MRCP (London) Associate Professor of Clinical Internal Medicine, Prisma Health -University of South Carolina, School of Medicine (USC SOM); Principal Investigator, South Carolina HIV/AIDS Training Center, USC SOM; Medical Director, Immunology Center, Prisma Health
Linda Brown, MPH Overdose Prevention Coord/Infectious Disease Consultant, SC DAODAS
Marya Barker, MPH Director, Core Surveillance Section, SC DHEC

Activity Number

0062-9999-22-122-L01-P

Date: 05/21/22

Time: 11:30 AM - 12:15 PM

CE Hours

0.75